125 related articles for article (PubMed ID: 3529516)
1. Evaluation of a rapid ultrafiltration technique for determination of quinidine protein binding and comparison with equilibrium dialysis.
Ha HR; Vozeh S; Follath F
Ther Drug Monit; 1986; 8(3):331-5. PubMed ID: 3529516
[TBL] [Abstract][Full Text] [Related]
2. Comparison of assay procedures used to measure total and unbound concentrations of quinidine.
Wooding-Scott RA; Darling IM; Slaughter RL
DICP; 1989 Dec; 23(12):999-1004. PubMed ID: 2690475
[TBL] [Abstract][Full Text] [Related]
3. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
[TBL] [Abstract][Full Text] [Related]
4. Quinidine assays: enzyme immunoassay versus high performance liquid chromatography.
Lehmann CR; Boran KJ; Pierson WP; Melikian AP; Wright GJ
Ther Drug Monit; 1986; 8(3):336-9. PubMed ID: 3529517
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography and fluorescence spectroscopy compared with a homogeneous enzyme immunoassay technique for determining quinidine in serum.
Drayer DE; Lorenzo B; Reidenberg MM
Clin Chem; 1981 Feb; 27(2):308-10. PubMed ID: 7006859
[TBL] [Abstract][Full Text] [Related]
6. Determination of free disopyramide plasma concentrations using ultrafiltration and enzyme multiplied immunoassay.
Raghow G; Meyer MC; Straughn AB
Ther Drug Monit; 1985; 7(4):466-71. PubMed ID: 3909539
[TBL] [Abstract][Full Text] [Related]
7. Determination of free thyroid hormones in animal serum/plasma using ultrafiltration in combination with ultra-fast liquid chromatography-tandem mass spectrometry.
Tanoue R; Kume I; Yamamoto Y; Takaguchi K; Nomiyama K; Tanabe S; Kunisue T
J Chromatogr A; 2018 Mar; 1539():30-40. PubMed ID: 29395158
[TBL] [Abstract][Full Text] [Related]
8. Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.
Stove V; Coene L; Carlier M; De Waele JJ; Fiers T; Verstraete AG
Ther Drug Monit; 2015 Apr; 37(2):180-7. PubMed ID: 25072945
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting the binding of disopyramide to serum proteins.
Shaw LM; Altman R; Thompson BC; Fields L
Clin Chem; 1985 Apr; 31(4):616-9. PubMed ID: 3884182
[TBL] [Abstract][Full Text] [Related]
10. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
Oellerich M; Müller-Vahl H
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
[TBL] [Abstract][Full Text] [Related]
11. Influence of the ORM1 phenotypes on serum unbound concentration and protein binding of quinidine.
Li JH; Xu JQ; Cao XM; Ni L; Li Y; Zhuang YY; Gong JB
Clin Chim Acta; 2002 Mar; 317(1-2):85-92. PubMed ID: 11814462
[TBL] [Abstract][Full Text] [Related]
12. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.
Drayer DE; Restivo K; Reidenberg MM
J Lab Clin Med; 1977 Nov; 90(5):816-22. PubMed ID: 908870
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the apparent protein binding of quinidine.
Guentert TW; Oie S
J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
[TBL] [Abstract][Full Text] [Related]
14. Altered therapeutic range for quinidine after myocardial infarction and cardiac surgery.
Garfinkel D; Mamelok RD; Blaschke TF
Ann Intern Med; 1987 Jul; 107(1):48-50. PubMed ID: 3109296
[TBL] [Abstract][Full Text] [Related]
15. Measurement of lidocaine free concentration.
Beach CL; Ludden TM; Clementi WA; Allerheiligen SR
Ther Drug Monit; 1986; 8(3):326-30. PubMed ID: 3529515
[TBL] [Abstract][Full Text] [Related]
16. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
[TBL] [Abstract][Full Text] [Related]
17. A high-pressure liquid chromatography method for serum quinidine and (3S)-3-hydroxyquinidine.
Weidner N; Ladenson JH; Larson L; Kessler G; McDonald JM
Clin Chim Acta; 1979 Jan; 91(1):7-13. PubMed ID: 761394
[TBL] [Abstract][Full Text] [Related]
18. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
Wooding-Scott RA; Visco J; Slaughter RL
Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
[TBL] [Abstract][Full Text] [Related]
19. Decreased quinidine plasma protein binding during hemodialysis.
Kessler KM; Perez GO
Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
[TBL] [Abstract][Full Text] [Related]
20. The application of a microcomputer for enzyme immunoassay (Emit) determination of serum quinidine concentrations.
Sealfon MS; Hallberg N
Am J Med Technol; 1983 Sep; 49(9):669-70. PubMed ID: 6372484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
